Biotechnology valuation - Karl D. Keegan
an introductory guide
Stockfoto
KORTE INHOUD
The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotec...
Categorie
Details
2008 Uitgever: John Wiley & Sons 218 paginas Taal: Engels ISBN-10: 0470511788 ISBN-13: 9780470511787Helaas, laatste exemplaar van deze editie is recent verkocht!